… Symptomatic treatment for Alzheimer's disease has focused … The goals of treatment in
patients with Alzheimer's disease … for Alzheimer's disease use the Alzheimer's Disease …

… Alzheimer's disease (AD) has been a long-standing challenge and area of interest. Advances
in knowledge of the pathogenesis of disease and an increase in disease … treatments of AD …

… Noncognitive symptoms and long-term treatment expectations for Alzheimer disease. … The
needs of the caregiver in the long-term treatment of Alzheimer disease. Alzheimer Dis Assoc …

… neurodegenerative disease. Current approved therapies are symptomatic treatments … the
focus of efforts to develop a disease modification treatment for AD but these approaches have …

… Alzheimer's disease (AD) is the most common neurodegenerative disorder and the most
prevalent cause of dementia with ageing. Pharmacological treatment … of the disease, but their …

… In this review we discuss current symptomatic treatments and new potential disease-modifying …
Treatment of behavioral and psychological symptoms of dementia in Alzheimer’s disease …

As a potential disease-modifying treatment for AD, Alzhemed (tramiprosate) is a compound
that binds to soluble amyloid-beta peptide (Aβ) and inhibits the formation of neurotoxic …

Background: Alzheimer's disease (AD), a progressive degenerative disorder of the brain, is
the most common cause of cognitive impairment in the elderly. The pharmacotherapy of AD …

… In trials to date, treatment of mild to moderate Alzheimer’s disease with anti-amyloid
therapies has resulted in the removal of amyloid, but the cognitive deficits of the disease …

Alzheimer's disease (AD) is the most common neurodegenerative disorder. Worldwide
prevalence of the disease is estimated at more than 24 million cases. With aging of populations, …